Revive Therapeutics Ltd C.RVV

Alternate Symbol(s): RVVTF

Healthcare Biotechnology

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).

CSE:RVV - Post by User

Revive Therapeutics Ltd > Race to zero

<< Previous

Bullboard Posts

Next >>

Comment by 1ottrunneron Mar 31, 2021 7:05am

156 Views

Post# 32912236

RE:RE:Race to zero

If the race is between your beloved LEXX ir RVV, LEXX is guaranteed to win. The company is a joke. You've made a mistake pulling your money out of RVV and dumping it into that steaming pile LXX and now you are crying over it.

LOL

LEXX will break into 30 cents pre consolidated value before the end of summer, any fool can see that.

LexluthorInc wrote:

LexluthorInc wrote: A covid pill could be coming sooner than you think. Think Tamiflu for covid. If Merck's drug works, it could be a gamechanger in the fight against this ever-mutating virus. w/@rileyraygriffin in this week's @BW $MRK https://t.co/Z2OWPVBqQe